Standard BioTools Inc. (NASDAQ: LAB)
$2.25
+0.1400 ( +6.63% ) 2.5M
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Market Data
Open
$2.25
Previous close
$2.11
Volume
2.5M
Market cap
$833.45M
Day range
$2.07 - $2.29
52 week range
$1.57 - $3.16
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 87 | Nov 07, 2023 |
4 | Insider transactions | 1 | Oct 20, 2023 |
8-k | 8K-related | 34 | Oct 04, 2023 |
8-k | 8K-related | 13 | Aug 08, 2023 |
10-q | Quarterly Reports | 87 | Aug 08, 2023 |
8-k | 8K-related | 18 | Jul 28, 2023 |